DOCSLIB.ORG

Microrna Binding Microrna Binding Probe Set Entrez Gene Gene

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Microrna Binding Microrna Binding Probe Set Entrez Gene Gene microRNA microRNA binding binding 4,6,7 - mir- down Entrez Gene fold 200bc_429 mir-429 344SQ vs Probe set Gene Gene Title Symbol change t test (TS) (Miranda) 393 P 1439760_x_at 22268 uroplakin 1B Upk1b 0.004183 0.000109 --- --- --- transcription 1421078_at 69852 factor 23 Tcf23 0.007771 0.000345 --- --- --- forkhead box 1418876_at 15229 D1 Foxd1 0.008388 0.000239 --- --- yes transmembra ne and immunoglobul in domain 1419498_at 66601 containing 1 Tmigd1 0.009243 0.000362 --- --- --- 1416808_at 18073 nidogen 1 Nid1 0.010386 5.86E-07 --- --- yes mast cell 1449989_at 17225 protease 2 Mcpt2 0.010768 6.88E-05 --- --- yes trimethyllysin e hydroxylase, 1420725_at 192289 epsilon Tmlhe 0.011638 0.000199 --- --- --- autism susceptibility 1427293_a_at 319974 candidate 2 Auts2 0.012768 0.000109 --- --- yes autism susceptibility 1457139_at 319974 candidate 2 Auts2 0.013934 9.24E-06 --- --- yes surfactant associated 1437028_at 20388 protein B Sftpb 0.015134 1.06E-05 --- --- yes cytochrome P450, family 4, subfamily f, polypeptide 1419559_at 64385 14 Cyp4f14 0.022232 0.000609 --- --- yes pancreatic and duodenal 1422174_at 18609 homeobox 1 Pdx1 0.023759 0.000595 --- --- yes cytochrome P450, family 2, subfamily c, polypeptide 1429994_s_at 72303 65 Cyp2c65 0.025334 0.001686 --- --- --- trimethyllysin e hydroxylase, 1420726_x_at 192289 epsilon Tmlhe 0.027041 0.000102 --- --- --- methyltransfe 1416980_at 71664 rase like 7B Mettl7b 0.027748 1.39E-06 --- --- --- UDP- Gal:betaGlcN Ac beta 1,4- galactosyltran sferase, 1425934_a_at 56375 polypeptide 4 B4galt4 0.030457 0.000676 --- --- --- fatty acid binding 1448764_a_at 14080 protein 1, liver Fabp1 0.034416 0.001979 --- --- --- RIKEN cDNA 1110032A04 1417803_at 66183 gene 1110032A0 0.035533 1.05E-06 --- --- --- apolipoprotein 1455593_at 238055 B Apob 0.035798 0.000725 --- --- yes transmembra ne protein 1424652_at 232146 166 Tmem166 0.036203 1.27E-05 --- --- yes autism susceptibility 1438680_at 319974 candidate 2 Auts2 0.039247 0.000176 --- --- yes dopa decarboxylas 1426215_at 13195 e Ddc 0.039407 4.85E-05 --- --- --- 1438702_at --- --- --- 0.039789 0.000309 --- --- --- anthrax toxin 1451446_at 69538 receptor 1 Antxr1 0.040359 2.00E-05 --- --- --- RIKEN cDNA C130038G02 1432205_a_at 77521 gene C130038G 0.042599 9.92E-05 --- --- --- monoamine 1434354_at 109731 oxidase B Maob 0.042847 0.001826 --- --- yes oncoprotein induced 1424502_at 18300 transcript 1 Oit1 0.043354 0.002933 --- --- --- glutathione S- transferase, 1421040_a_at 14858 alpha 2 (Yc2) Gsta2 0.044944 5.57E-05 --- --- --- histocompatib 1457769_at 15101 ility 60 H60 0.045262 4.77E-05 --- --- --- 1416203_at 11826 aquaporin 1 Aqp1 0.047137 0.003143 --- --- --- RIKEN cDNA 4930486G11 1437935_at 75033 gene 4930486G1 0.049233 0.004104 --- yes --- 1455096_at --- --- --- 0.049538 4.81E-05 --- --- --- 1427352_at 223917 keratin 79 Krt79 0.049811 0.000357 --- --- --- inter-alpha (globulin) 1441946_at 209378 inhibitor H5 Itih5 0.049839 0.00252 --- --- --- X-linked lymphocyte- regulated complex /// RIKEN cDNA 3830403N18 1422011_s_at 22441 /// gene Xlr /// 38304 0.050801 2.47E-05 --- --- --- progestin and adipoQ receptor family 1423101_at 76498 member IV Paqr4 0.052694 0.001786 --- --- --- complement 1417314_at 14962 factor B Cfb 0.053634 0.001331 --- --- --- sphingosine-1- phosphate phosphotase 1457867_at 433323 2 Sgpp2 0.054575 0.001077 --- --- --- RIKEN cDNA 1110032A04 1417802_at 66183 gene 1110032A0 0.054592 5.28E-05 --- --- --- 1449244_at 12558 cadherin 2 Cdh2 0.055551 0.000235 --- --- yes retinoic acid early transcript 1, alpha /// retinoic acid early transcript beta /// retinoic acid early transcript gamma /// retinoic acid early transcript delta /// retinoic acid early 1420603_s_at 19368 /// transcript 1E Raet1a /// R 0.060713 0.000489 --- --- --- RIKEN cDNA 3110009F21 1430198_at 67280 gene 3110009F2 0.062266 0.000649 --- --- --- 1418815_at 12558 cadherin 2 Cdh2 0.065321 0.000185 --- --- yes 1434112_at 99633 latrophilin 2 Lphn2 0.066239 0.000467 --- --- --- cDNA sequence 1440218_at 268663 BC040758 BC040758 0.068266 0.000769 --- --- yes interferon gamma inducible 1417292_at 15953 protein 47 Ifi47 0.073506 0.005944 --- --- --- glutathione S- transferase, alpha 1 (Ya) /// glutathione S-transferase, 1421041_s_at 14857 /// alpha 2 (Yc2) Gsta1 /// G 0.073872 0.002131 --- --- --- calmodulin- 1424713_at 75600 like 4 Calml4 0.074934 0.000863 --- --- --- RAB27A, member RAS oncogene 1429123_at 11891 family Rab27a 0.075531 2.20E-05 --- --- --- RIKEN cDNA D930005D10 1433523_at 231858 gene D930005D 0.078697 0.002234 --- --- --- selenium binding 1450699_at 20341 protein 1 Selenbp1 0.07896 0.006171 --- --- yes mast cell 1422352_at 17224 protease 1 Mcpt1 0.080626 0.000343 --- --- yes 1429287_a_at 19109 prolactin Prl 0.080701 0.003078 --- --- --- similar to solute carrier family 7 (cationic amino acid transporter, y+ system), 1435154_at 245128 member 3 LOC24512 0.081714 9.15E-06 --- --- --- zinc finger 1460078_at 244216 protein 771 Zfp771 0.081883 5.77E-05 --- --- --- kalirin, RhoGEF 1429796_at 545156 kinase Kalrn 0.081996 0.000485 --- --- --- serine (or cysteine) peptidase inhibitor, clade B, 1422668_at 20706 member 9b Serpinb9b 0.082829 0.000364 --- --- --- 1438452_at 74103 nebulette Nebl 0.087288 0.000144 --- --- yes RIKEN cDNA A530088I07 1435596_at 212167 gene A530088I0 0.090158 0.008044 --- --- --- ets variant 1450684_at 14009 gene 1 Etv1 0.092174 0.003095 --- --- --- cDNA sequence 1459904_at 407795 BC030870 BC030870 0.092444 0.004732 --- --- --- pancreatic and duodenal 1422173_at 18609 homeobox 1 Pdx1 0.093304 0.008459 --- --- --- cDNA sequence 1440094_at 407795 BC030870 BC030870 0.093714 0.00461 --- --- --- prokineticin 1456543_at 58182 receptor 1 Prokr1 0.095084 5.98E-05 --- --- yes RIKEN cDNA 1300007C21 gene /// predicted gene, EG668462 /// predicted gene, EG668581 /// hypothetical protein LOC670993 /// hypothetical protein 1431213_a_at 668462 //LOC673100 1300007C2 0.095558 0.000697 --- --- --- 3'- phosphoaden osine 5'- phosphosulfat 1434510_at 23972 e synthase 2 Papss2 0.098137 7.99E-05 --- --- yes cDNA sequence 1425712_at 223631 BC025446 BC025446 0.098634 0.000465 --- yes --- gene model 1426619_at 383619 1313, (NCBI) Gm1313 0.099418 0.009405 --- --- --- UDP- GalNAc:beta GlcNAc beta 1,3- galactosamin yltransferase, 1418736_at 26879 polypeptide 1 B3galnt1 0.101262 0.001385 --- --- --- RAB27A, member RAS oncogene 1425284_a_at 11891 family Rab27a 0.10201 1.99E-05 --- --- --- protein tyrosine phosphatase, receptor type, 1422541_at 19274 M Ptprm 0.104966 0.003953 --- --- yes 3'- phosphoaden osine 5'- phosphosulfat 1421989_s_at 23972 e synthase 2 Papss2 0.106476 0.001007 --- --- yes solute carrier family 12 (potassium/ch loride transporters), 1420334_at 171286 member 8 Slc12a8 0.107252 0.006345 --- --- --- CEA-related cell adhesion 1452532_x_at 26365 molecule 1 Ceacam1 0.109398 0.005745 --- yes --- peripheral 1417133_at 18858 myelin protein Pmp22 0.112447 1.58E-05 --- --- --- SRY-box containing 1447655_x_at 20679 gene 6 Sox6 0.11455 0.000105 --- yes --- G protein- coupled 1439795_at 237175 receptor 64 Gpr64 0.114977 0.009907 --- --- --- gene model 1435283_s_at 381217 967, (NCBI) Gm967 0.117665 0.007962 --- --- --- microtubule associated monoxygenas e, calponin and LIM domain 1456439_x_at 171580 containing 1 Mical1 0.118318 0.009861 --- --- yes solute carrier organic anion transporter family, 1420913_at 24059 member 2a1 Slco2a1 0.119862 0.00102 --- yes --- Amyloid beta (A4) precursor protein- binding, family A, member 1 binding 1447907_x_at 56846 protein Apba2bp 0.120579 0.007291 --- --- --- ATP-binding cassette, sub- family G (WHITE), 1423570_at 11307 member 1 Abcg1 0.121543 0.007204 --- --- --- heat shock 1436961_at 73442 protein 12A Hspa12a 0.124121 0.004096 --- yes --- RIKEN cDNA 4631423F02 1452707_at 70788 gene 4631423F0 0.125775 0.000233 --- --- yes Aconitase 2, 1440145_at 11429 mitochondrial Aco2 0.126035 0.000191 --- --- --- BMP and activin membrane- bound inhibitor, homolog (Xenopus 1423753_at 68010 laevis) Bambi 0.129682 0.008079 --- --- --- kelch repeat and BTB (POZ) domain 1435465_at 74901 containing 11 Kbtbd11 0.130115 0.000576 --- --- --- RIKEN cDNA A330021E22 1440796_at 207686 gene A330021E2 0.130771 0.002547 --- --- yes RIKEN cDNA A930015G24 1432222_at 77808 gene A930015G2 0.131208 0.002793 --- --- --- 1434345_at 212070 clarin 3 Clrn3 0.131497 0.003521 --- --- --- coiled-coil domain 1424186_at 67896 containing 80 Ccdc80 0.132304 0.005235 --- --- --- guanylate cyclase activator 2a 1416905_at 14915 (guanylin) Guca2a 0.132777 6.56E-05 --- --- --- cytochrome b- 245, alpha 1454268_a_at 13057 polypeptide Cyba 0.13321 0.003729 --- --- --- Park2 co- 1428751_at 69310 regulated Pacrg 0.133928 0.002705 --- --- yes RIKEN cDNA 4930513N10 1441278_at 319960 gene 4930513N1 0.134711 0.009756 --- --- --- SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, 1460292_a_at 93761 member 1 Smarca1 0.135434 0.000775 --- yes --- 1443770_x_at --- --- --- 0.136444 0.00374 --- --- yes nucleosome assembly protein 1-like 1418500_at 54561 3 Nap1l3 0.137364 0.005748 --- --- --- sodium channel, voltage- gated, type II, 1435933_at 110876 alpha 1 Scn2a1 0.138839 0.001972 --- --- --- solute carrier organic anion transporter family, 1450032_at 24059 member 2a1 Slco2a1 0.140029 0.000722 --- yes --- RIKEN cDNA 7530403E16 1457260_at 100224 gene 7530403E1 0.141284 2.14E-05 --- --- yes procollagen, type XIV, 1427168_a_at 12818 alpha 1 Col14a1 0.142722 0.000698 --- --- --- kelch-like 13 1448269_a_at 67455 (Drosophila) Klhl13 0.144291 2.65E-05 --- ---
Load more

Recommended publications
  • Ccdc80 and Ccdc80-L1: Identification and Functional Analysis of Two Novel Genes Involved in Zebrafish (Danio Rerio) Development
    UNIVERSITÀ DEGLI STUDI DI MILANO SCUOLA DI DOTTORATO IN SCIENZE BIOLOGICHE E MOLECOLARI DIPARTIMENTO DI BIOLOGIA DOTTORATO DI RICERCA IN BIOLOGIA CELLULARE E MOLECOLARE XXIV CICLO ccdc80 and ccdc80-l1: Identification and Functional Analysis of Two Novel Genes Involved in Zebrafish (Danio rerio) Development settori scientifico/disciplinari: BIO/06; BIO/11 Tesi di dottorato di Chiara Brusegan R08215 TUTOR: prof. Franco Cotelli COORDINATORE DEL DOTTORATO: prof. Martino Bolognesi A.A. 2010/2011 Index Part I 1. Abstract 1 2. State of the art 2 2.1 Motility of the zebrafish embryo 2 2.2 Muscle formation 3 2.3 Neural differentiation 6 2.4 Identification of zebrafish ccdc80 genes 9 3. Aim of the project 13 4. Materials and Methods 14 4.1 Zebrafish lines and maintenance 14 4.2 Sequence analysis 14 4.3 RT-PCR 15 4.4 Synthesis of probes for whole mount in situ hybridization (WISH) 16 4.5 Whole-mount in situ hybridization 17 4.6 Immunohistochemistry 17 4.7 Histological sections 18 4.8 Injections 18 4.9 Cyclopamine treatment 19 4.10 Statistical analysis 19 5. Results 20 5.1 Identification of ccdc80 homologs in the genome of zebrafish 20 5.2.1 ccdc80 expression profiling 22 5.2.2 ccdc80-loss- and gain-of-function affects somitogenesis in vivo 23 5.2.3 ccdc80 is involved in somitogenesis, but not in the development of the notochord 25 5.2.4 ccdc80 is positively regulated by the Hedgehog pathway 26 5.3.1 ccdc80-l1 expression profiling 27 5.3.2 ccdc80-l1 knocked-down embryos displayed impaired motility 29 5.3.3 ccdc80-l1 loss of function does not affect somitogenesis nor muscle pioneers and adaxial cells formation 30 5.3.4 analysis of neurogenesis of primary motoneurons in ccdc80-l1 morphants 32 5.3.5 Also ccdc80-l1 expression is positively regulated by the Hedgehog pathway 35 5.4.1 ccdc80 expression is not regulated by ccdc80-l1, nor vice versa 37 6.
    [Show full text]
  • Mechanical Forces Induce an Asthma Gene Signature in Healthy Airway Epithelial Cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T
    www.nature.com/scientificreports OPEN Mechanical forces induce an asthma gene signature in healthy airway epithelial cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T. Kho4, Kelan Tantisira1, Marc Santolini 1,5, Feixiong Cheng6,7,8, Jennifer A. Mitchel3, Maureen McGill3, Michael J. O’Sullivan3, Margherita De Marzio1,3, Amitabh Sharma1, Scott H. Randell9, Jefrey M. Drazen3, Jefrey J. Fredberg3 & Scott T. Weiss1,3* Bronchospasm compresses the bronchial epithelium, and this compressive stress has been implicated in asthma pathogenesis. However, the molecular mechanisms by which this compressive stress alters pathways relevant to disease are not well understood. Using air-liquid interface cultures of primary human bronchial epithelial cells derived from non-asthmatic donors and asthmatic donors, we applied a compressive stress and then used a network approach to map resulting changes in the molecular interactome. In cells from non-asthmatic donors, compression by itself was sufcient to induce infammatory, late repair, and fbrotic pathways. Remarkably, this molecular profle of non-asthmatic cells after compression recapitulated the profle of asthmatic cells before compression. Together, these results show that even in the absence of any infammatory stimulus, mechanical compression alone is sufcient to induce an asthma-like molecular signature. Bronchial epithelial cells (BECs) form a physical barrier that protects pulmonary airways from inhaled irritants and invading pathogens1,2. Moreover, environmental stimuli such as allergens, pollutants and viruses can induce constriction of the airways3 and thereby expose the bronchial epithelium to compressive mechanical stress. In BECs, this compressive stress induces structural, biophysical, as well as molecular changes4,5, that interact with nearby mesenchyme6 to cause epithelial layer unjamming1, shedding of soluble factors, production of matrix proteins, and activation matrix modifying enzymes, which then act to coordinate infammatory and remodeling processes4,7–10.
    [Show full text]
  • ALS2CR2 (STRADB) 406-418) Goat Polyclonal Antibody – AP08962PU-N
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AP08962PU-N ALS2CR2 (STRADB) 406-418) Goat Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: ELISA, IHC, WB Recommended Dilution: ELISA: 1/32000. Immunohistochemistry on Paraffin Sections: 3.75 µg/ml. Western Blot: 1 - 3 µg/ml. Reactivity: Canine, Human Host: Goat Clonality: Polyclonal Immunogen: Synthetic peptide from C-terminus of human ALS2CR2 Specificity: This antibody reacts to STE20-Related Kinase Adaptor Beta (STRADB/ALS2CR2) at aa 406-418. It is expected to recognise both human isoforms: ILPIP-alpha (NP_061041.2) and ILPIP-beta (AAF71042.1). Formulation: Tris saline buffer, pH 7.3, 0.5% BSA, 0.02% sodium azide State: Aff - Purified State: Liquid purified Ig Concentration: lot specific Purification: Immunoaffinity Chromatography Conjugation: Unconjugated Storage: Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. Database Link: Entrez Gene 55437 Human Q9C0K7 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 ALS2CR2 (STRADB) 406-418) Goat Polyclonal Antibody – AP08962PU-N Background: Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2, is connected to transferase/kinase activity and ATP binding, it has recently been shown to interact with XIAP, a member of the IAP (Inhibitor of Apoptosis) protein family.
    [Show full text]
  • Regulation of Cdc42 and Its Effectors in Epithelial Morphogenesis Franck Pichaud1,2,*, Rhian F
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs217869. doi:10.1242/jcs.217869 REVIEW SUBJECT COLLECTION: ADHESION Regulation of Cdc42 and its effectors in epithelial morphogenesis Franck Pichaud1,2,*, Rhian F. Walther1 and Francisca Nunes de Almeida1 ABSTRACT An overview of Cdc42 Cdc42 – a member of the small Rho GTPase family – regulates cell Cdc42 was discovered in yeast and belongs to a large family of small – polarity across organisms from yeast to humans. It is an essential (20 30 kDa) GTP-binding proteins (Adams et al., 1990; Johnson regulator of polarized morphogenesis in epithelial cells, through and Pringle, 1990). It is part of the Ras-homologous Rho subfamily coordination of apical membrane morphogenesis, lumen formation and of GTPases, of which there are 20 members in humans, including junction maturation. In parallel, work in yeast and Caenorhabditis elegans the RhoA and Rac GTPases, (Hall, 2012). Rho, Rac and Cdc42 has provided important clues as to how this molecular switch can homologues are found in all eukaryotes, except for plants, which do generate and regulate polarity through localized activation or inhibition, not have a clear homologue for Cdc42. Together, the function of and cytoskeleton regulation. Recent studies have revealed how Rho GTPases influences most, if not all, cellular processes. important and complex these regulations can be during epithelial In the early 1990s, seminal work from Alan Hall and his morphogenesis. This complexity is mirrored by the fact that Cdc42 can collaborators identified Rho, Rac and Cdc42 as main regulators of exert its function through many effector proteins.
    [Show full text]
  • Supplemental Table S1
    Entrez Gene Symbol Gene Name Affymetrix EST Glomchip SAGE Stanford Literature HPA confirmed Gene ID Profiling profiling Profiling Profiling array profiling confirmed 1 2 A2M alpha-2-macroglobulin 0 0 0 1 0 2 10347 ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7 1 0 0 0 0 3 10350 ABCA9 ATP-binding cassette, sub-family A (ABC1), member 9 1 0 0 0 0 4 10057 ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 1 0 0 0 0 5 10060 ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 1 0 0 0 0 6 79575 ABHD8 abhydrolase domain containing 8 1 0 0 0 0 7 51225 ABI3 ABI gene family, member 3 1 0 1 0 0 8 29 ABR active BCR-related gene 1 0 0 0 0 9 25841 ABTB2 ankyrin repeat and BTB (POZ) domain containing 2 1 0 1 0 0 10 30 ACAA1 acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiol 0 1 0 0 0 11 43 ACHE acetylcholinesterase (Yt blood group) 1 0 0 0 0 12 58 ACTA1 actin, alpha 1, skeletal muscle 0 1 0 0 0 13 60 ACTB actin, beta 01000 1 14 71 ACTG1 actin, gamma 1 0 1 0 0 0 15 81 ACTN4 actinin, alpha 4 0 0 1 1 1 10700177 16 10096 ACTR3 ARP3 actin-related protein 3 homolog (yeast) 0 1 0 0 0 17 94 ACVRL1 activin A receptor type II-like 1 1 0 1 0 0 18 8038 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 1 0 0 0 0 19 8751 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 1 0 0 0 0 20 8728 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 1 0 0 0 0 21 81792 ADAMTS12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 1 0 0 0 0 22 9507 ADAMTS4 ADAM metallopeptidase with thrombospondin type 1
    [Show full text]
  • Entrez Symbols Name Termid Termdesc 117553 Uba3,Ube1c
    Entrez Symbols Name TermID TermDesc 117553 Uba3,Ube1c ubiquitin-like modifier activating enzyme 3 GO:0016881 acid-amino acid ligase activity 299002 G2e3,RGD1310263 G2/M-phase specific E3 ubiquitin ligase GO:0016881 acid-amino acid ligase activity 303614 RGD1310067,Smurf2 SMAD specific E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 308669 Herc2 hect domain and RLD 2 GO:0016881 acid-amino acid ligase activity 309331 Uhrf2 ubiquitin-like with PHD and ring finger domains 2 GO:0016881 acid-amino acid ligase activity 316395 Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 361866 Hace1 HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 GO:0016881 acid-amino acid ligase activity 117029 Ccr5,Ckr5,Cmkbr5 chemokine (C-C motif) receptor 5 GO:0003779 actin binding 117538 Waspip,Wip,Wipf1 WAS/WASL interacting protein family, member 1 GO:0003779 actin binding 117557 TM30nm,Tpm3,Tpm5 tropomyosin 3, gamma GO:0003779 actin binding 24779 MGC93554,Slc4a1 solute carrier family 4 (anion exchanger), member 1 GO:0003779 actin binding 24851 Alpha-tm,Tma2,Tmsa,Tpm1 tropomyosin 1, alpha GO:0003779 actin binding 25132 Myo5b,Myr6 myosin Vb GO:0003779 actin binding 25152 Map1a,Mtap1a microtubule-associated protein 1A GO:0003779 actin binding 25230 Add3 adducin 3 (gamma) GO:0003779 actin binding 25386 AQP-2,Aqp2,MGC156502,aquaporin-2aquaporin 2 (collecting duct) GO:0003779 actin binding 25484 MYR5,Myo1e,Myr3 myosin IE GO:0003779 actin binding 25576 14-3-3e1,MGC93547,Ywhah
    [Show full text]
  • Broad Poster Vivek
    A novel computational method for finding regions with copy number abnormalities in cancer cells Vivek, Manuel Garber, and Mike Zody Broad Institute of MIT and Harvard, Cambridge, MA, USA Introduction Results Cancer can result from the over expression of oncogenes, genes which control and regulate cell growth. Sometimes oncogenes increase in 1 2 3 activity due to a specific genetic mutation called a translocation (Fig 1). SMAD4 – a gene known to be deleted in pancreatic COX10 – a gene deleted in cytochrome c oxidase AK001392 – a hereditary prostate cancer protein This translocation allows the oncogene to remain as active as its paired carcinoma deficiency, known to be related to cell proliferation gene. Amplification of this mutation can occur, thereby creating the proper conditions for uncontrolled cell growth; consequently, each Results from Analysis Program Results from Analysis Program Results from Analysis Program component of the translocation will amplify in similar quantities. In this mutation, the chromosomal region containing the oncogene displaces to Region 1 Region 2 R2 Region 1 Region 2 R2 Region 1 Region 2 R2 a region on another chromosome containing a gene that is expressed Chr18:47044749-47311978 Chr17:13930739-14654741 0.499070821478475 Chr17:13930739-14654741 Chr18:26861790-27072166 0.47355172850856 Chr17:12542326-13930738 Chr8:1789292-1801984 0.406208680312004 frequently. Actual region containing gene Actual region containing gene Actual region containing gene chr18: 45,842,214 - 48,514,513 chr17: 13,966,862 - 14,068,461 chr17: 12,542,326 - 13,930,738 Fig 1. Two chromosomal regions (abcdef and ghijk) are translocating to create two new regions (abckl and ghijedf).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Bioinformatics Analyses of Genomic Imprinting
    Bioinformatics Analyses of Genomic Imprinting Dissertation zur Erlangung des Grades des Doktors der Naturwissenschaften der Naturwissenschaftlich-Technischen Fakultät III Chemie, Pharmazie, Bio- und Werkstoffwissenschaften der Universität des Saarlandes von Barbara Hutter Saarbrücken 2009 Tag des Kolloquiums: 08.12.2009 Dekan: Prof. Dr.-Ing. Stefan Diebels Berichterstatter: Prof. Dr. Volkhard Helms Priv.-Doz. Dr. Martina Paulsen Vorsitz: Prof. Dr. Jörn Walter Akad. Mitarbeiter: Dr. Tihamér Geyer Table of contents Summary________________________________________________________________ I Zusammenfassung ________________________________________________________ I Acknowledgements _______________________________________________________II Abbreviations ___________________________________________________________ III Chapter 1 – Introduction __________________________________________________ 1 1.1 Important terms and concepts related to genomic imprinting __________________________ 2 1.2 CpG islands as regulatory elements ______________________________________________ 3 1.3 Differentially methylated regions and imprinting clusters_____________________________ 6 1.4 Reading the imprint __________________________________________________________ 8 1.5 Chromatin marks at imprinted regions___________________________________________ 10 1.6 Roles of repetitive elements ___________________________________________________ 12 1.7 Functional implications of imprinted genes _______________________________________ 14 1.8 Evolution and parental conflict ________________________________________________
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0264.634 A1 Amersdorfer Et Al
    US 20120264.634A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0264.634 A1 Amersdorfer et al. (43) Pub. Date: Oct. 18, 2012 (54) MARKER SEQUENCES FOR PANCREATIC Publication Classification CANCER DISEASES, PANCREATIC (51) Int. Cl. CARCINOMIA AND USE THEREOF C40B 30/04 (2006.01) GOIN 2L/64 (2006.01) (75) Inventors: Peter Amersdorfer, Graz (AT); GOIN 27/72 (2006.01) Annabel Höpfner, Dortmund (DE); C07K I4/435 (2006.01) Angelika Lueking, Bochum (DE) C40B 40/06 (2006.01) C40B 40/10 (2006.01) CI2N 5/09 (2010.01) (73) Assignee: PROTAGEN Aktiengesellschaft, C7H 2L/04 (2006.01) Dortmund (DE) GOIN 33/574 (2006.01) GOIN 27/62 (2006.01) (21) Appl. No.: 13/498,964 (52) U.S. Cl. ........... 506/9:436/501; 435/6.14; 435/7.92; 506/16:506/18: 435/2:536/23.1; 530/350 (22) PCT Filed: Sep. 29, 2010 (57) ABSTRACT The present invention relates to novel marker sequences for (86). PCT No.: PCT/EP2010/064510 pancreatic cancer diseases, pancreatic carcinoma and the diagnostic use thereof together with a method for Screening of S371 (c)(1), potential active Substances for pancreatic cancer diseases, (2), (4) Date: Jun. 22, 2012 pancreatic carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device con (30) Foreign Application Priority Data taining Such marker sequences for pancreatic cancer diseases, pancreatic carcinoma, in particular a protein biochip and the Sep. 29, 2009 (EP) .................................. O9171690.2 use thereof. Patent Application Publication Oct. 18, 2012 US 2012/0264.634 A1 US 2012/0264.634 A1 Oct.
    [Show full text]
  • A Single-Cell Transcriptomic Landscape of Primate Arterial Aging
    ARTICLE https://doi.org/10.1038/s41467-020-15997-0 OPEN A single-cell transcriptomic landscape of primate arterial aging Weiqi Zhang 1,2,3,4,5,13, Shu Zhang6,7,13, Pengze Yan3,8,13, Jie Ren7,9,13, Moshi Song3,5,8, Jingyi Li2,3,8, Jinghui Lei4, Huize Pan2,3, Si Wang3,5,8, Xibo Ma3,10, Shuai Ma2,3,8, Hongyu Li2,3, Fei Sun2,3, Haifeng Wan3,5,11, ✉ ✉ ✉ Wei Li 3,5,11, Piu Chan4, Qi Zhou3,5,11, Guang-Hui Liu 2,3,4,5,8 , Fuchou Tang 6,7,9,12 & Jing Qu 3,5,11 Our understanding of how aging affects the cellular and molecular components of the vas- 1234567890():,; culature and contributes to cardiovascular diseases is still limited. Here we report a single-cell transcriptomic survey of aortas and coronary arteries in young and old cynomolgus monkeys. Our data define the molecular signatures of specialized arteries and identify eight markers discriminating aortic and coronary vasculatures. Gene network analyses characterize tran- scriptional landmarks that regulate vascular senility and position FOXO3A, a longevity- associated transcription factor, as a master regulator gene that is downregulated in six subtypes of monkey vascular cells during aging. Targeted inactivation of FOXO3A in human vascular endothelial cells recapitulates the major phenotypic defects observed in aged monkey arteries, verifying FOXO3A loss as a key driver for arterial endothelial aging. Our study provides a critical resource for understanding the principles underlying primate arterial aging and contributes important clues to future treatment of age-associated vascular disorders. 1 CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
    [Show full text]
  • Methods in and Applications of the Sequencing of Short Non-Coding Rnas" (2013)
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2013 Methods in and Applications of the Sequencing of Short Non- Coding RNAs Paul Ryvkin University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, Genetics Commons, and the Molecular Biology Commons Recommended Citation Ryvkin, Paul, "Methods in and Applications of the Sequencing of Short Non-Coding RNAs" (2013). Publicly Accessible Penn Dissertations. 922. https://repository.upenn.edu/edissertations/922 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/922 For more information, please contact [email protected]. Methods in and Applications of the Sequencing of Short Non-Coding RNAs Abstract Short non-coding RNAs are important for all domains of life. With the advent of modern molecular biology their applicability to medicine has become apparent in settings ranging from diagonistic biomarkers to therapeutics and fields angingr from oncology to neurology. In addition, a critical, recent technological development is high-throughput sequencing of nucleic acids. The convergence of modern biotechnology with developments in RNA biology presents opportunities in both basic research and medical settings. Here I present two novel methods for leveraging high-throughput sequencing in the study of short non- coding RNAs, as well as a study in which they are applied to Alzheimer's Disease (AD). The computational methods presented here include High-throughput Annotation of Modified Ribonucleotides (HAMR), which enables researchers to detect post-transcriptional covalent modifications ot RNAs in a high-throughput manner. In addition, I describe Classification of RNAs by Analysis of Length (CoRAL), a computational method that allows researchers to characterize the pathways responsible for short non-coding RNA biogenesis.
    [Show full text]